Aurélien Mary
Impact in
- Nephrology top 5%
- Parathyroid Disorders and Treatments
- Dialysis and Renal Disease Management
- Geriatrics and Gerontology top 5%
- Pharmaceutical Practices and Patient Outcomes
- Sirtuins and Resveratrol in Medicine
Papers in
- Nephrology 12
- Parathyroid Disorders and Treatments 8
- Dialysis and Renal Disease Management 3
- Chronic Kidney Disease and Diabetes 2
-
- Pharmaceutical Practices and Patient Outcomes 4
- Co-authors
- Saı̈d Kamel (12 shared papers)Ziad A. Massy (10 shared papers)Lucie Hénaut (5 shared papers)Michel Brazier (13 shared papers)Romuald Mentaverri (9 shared papers)Aurélie Lenglet (6 shared papers)Sophie Liabeuf (5 shared papers)Jean‐Marc Chillon (1 shared paper)
- Journals
- Toxins (2 papers)Nephrology Dialysis Transplantation (2 papers)Frontiers in Pharmacology (2 papers)International Journal of Pharmacy Practice (1 paper)Cardiovascular Diabetology (1 paper)
- Partner nations
- FranceSwitzerland
In The Last Decade
Aurélien Mary
22 papers receiving 554 citations
Peers
Comparison fields: 5 of 63
- Nephrology 265
- Geriatrics and Gerontology 80
- Family Practice 9
- Pharmacology 27
- Rheumatology 27
Countries citing papers authored by Aurélien Mary
This map shows the geographic impact of Aurélien Mary's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aurélien Mary with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aurélien Mary more than expected).
Fields of papers citing papers by Aurélien Mary
This network shows the impact of papers produced by Aurélien Mary. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aurélien Mary. The network helps show where Aurélien Mary may publish in the future.
Co-authors
The 25 scholars most cited alongside Aurélien Mary, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 83 | |
| 2 | 2013 | 71 | |
| 3 | 2016 | 71 | |
| 4 | 2016 | 58 | |
| 5 | 2017 | 50 | |
| 6 | 2017 | 48 | |
| 7 | 2015 | 36 | |
| 8 | 2018 | 27 | |
| 9 | 2022 | 23 | |
| 10 | 2016 | 16 | |
| 11 | 2021 | 13 | |
| 12 | 2020 | 10 | |
| 13 | 2013 | 9 | |
| 14 | 2020 | 8 | |
| 15 | 2021 | 8 | |
| 16 | 2017 | 7 | |
| 17 | 2021 | 6 | |
| 18 | 2020 | 5 | |
| 19 | 2019 | 4 | |
| 20 | 2017 | 3 |
About Aurélien Mary
Aurélien Mary is a scholar working on Nephrology, Geriatrics and Gerontology, Infectious Diseases, Analytical Chemistry and Endocrinology, Diabetes and Metabolism, having authored 28 papers that have together received 558 indexed citations. Recurring topics across this work include Parathyroid Disorders and Treatments (8 papers), Pharmaceutical Practices and Patient Outcomes (4 papers), Dialysis and Renal Disease Management (3 papers), Analytical Methods in Pharmaceuticals (2 papers), COVID-19 Clinical Research Studies (2 papers), Chronic Kidney Disease and Diabetes (2 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers) and Vitamin D Research Studies (2 papers). The work is most often cited by research in Nephrology (265 citations), Geriatrics and Gerontology (80 citations), Family Practice (9 citations), Pharmacology (27 citations) and Rheumatology (27 citations). Aurélien Mary has collaborated with scholars based in France and Switzerland. Frequent co-authors include Saı̈d Kamel, Ziad A. Massy, Lucie Hénaut, Michel Brazier, Romuald Mentaverri, Aurélie Lenglet, Sophie Liabeuf, Jean‐Marc Chillon, Tilman Bernhard Drüeke and Cédric Boudot. Their work appears in journals such as Toxins, Nephrology Dialysis Transplantation, Frontiers in Pharmacology, International Journal of Pharmacy Practice and Cardiovascular Diabetology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.